The Impact of TAVI Nurse Coordinator on patient management of Transcatheter Aortic Valve Implantation (TAVI) program in QEH

Similar documents
Transcatheter Aortic Valve Implantation (TAVI)

3 years after introduction of TAVI in QEH. Michael KY Lee On Behalf of QEH TAVI Heart Team Queen Elizabeth Hospital Hong Kong

Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee

Transcatheter Aortic Valve Implantation (TAVI) The Time Has Come

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

A new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Disclosures. LGH TAVR: Presentation Outline 2/2/2016. Updates in Transcatheter Aortic Valve Replacement (TAVR) and the LGH Experience

Transcatheter Aortic Valve Replacement

30-Day Outcomes Following Implantation of a Repositionable Self-Expanding Aortic Bioprosthesis: First Report From the FORWARD Study

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre

The Role of TAVI in high-risk and normal-risk Patients

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

Disclosures. During the past 12 months, I have received research grants, advisory boards, consultation fees/honoraria, and/or travel expenses from:

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France

Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update

Clinical & Practical Aspects of Establishing a Successful Heart & Valve Clinic

Results of Transfemoral Transcatheter Aortic Valve Implantation

David Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS. Peripheral Complications of TAVR

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

Indication, Timing, Assessment and Update on TAVI

22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2.

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Transcatheter Valve Replacement: Current State in 2017

TAVR and Cardiac Surgeons

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Aortic valve implantation using the femoral and apical access: a single center experience.

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Percutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis

Post-TAVI Cerebral Embolisms and Potential Protection Means

TAVI After PARTNER-2 : The Hamilton Approach

TAVR: Intermediate Risk Patients

TAVR in 2020: What is Next!!!!

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

Transcatheter Aortic Valve Implantation Anaesthetic Prespectives

Multicentre clinical study evaluating a novel resheatable self-expanding transcatheter aortic valve system

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Transcatheter Aortic Valve Implantation Present Status and Perspectives

TAVR IN INTERMEDIATE-RISK PATIENTS

Percutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update

TAVI in Korea, How to Avoid Conduction

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

SAPIEN 3: Evaluation of a Balloon- Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Transcatheter aortic valve implantation and pre-procedural risk assesment

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Emergency TAVI: Does It Exist? Is the Risk Higher?

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS

Aortic Stenosis: Background

For the SURTAVI Investigators

Policy Specific Section: March 30, 2012 March 7, 2013

Le TAVI pour tout le monde?

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

1-YEAR OUTCOMES FROM JOHN WEBB, MD

Istanbul Course of Interventional Cardiology Istanbul, June 11, 2011

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients

Transcatheter Aortic Valve Implantation (TAVI) Overview for Wales. Dr Richard Anderson University Hospital of Wales, Cardiff, UK

Ian T. Meredith AM. MBBS, PhD, FRACP, FCSANZ, FACC, FAPSIC. Monash HEART, Monash Health & Monash University Melbourne, Australia

Complicanze durante TAVI. Brambilla Nedy IRCCS Policlinico San Donato

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

The SAPIEN 3 TAVI Advantage

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Centers for Medicare and Medicaid Services. National Coverage of Transcatheter Valve Technologies December 2015

The Transcatheter Aortic Valve Replacement (TAVR)Program at Southcoast Health. Adam J. Saltzman, MD Cardiovascular Care Center

TAVI: Nouveaux Horizons

Tissue vs Mechanical What s the Data??

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Transcatheter Aortic Valve Replacement with Evolut-R

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves Trial II

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Trans Catheter Aortic Valve Replacement

Masterclass III Advances in cardiac intervention. Percutaneous valvular intervention a novel approach

Establishing the New Standard of Care for Inoperable Aortic Stenosis THE PARTNER TRIAL COHORT B RESULTS

Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients?

Bernard De Bruyne, MD, PhD Cardiovascular Center Aalst OLV-Clinic Aalst, Belgium

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Transcatheter Aortic-Valve Implantation for Aortic Stenosis

Summary Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Transcatheter Aortic-Valve Implantation for Aortic Stenosis

2/4/2019. Nursing Perspective of TAVR. Disclosure. Learning Outcomes

Surgery: The Gold Standard treatment for Aortic Stenosis

TAVR Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory. Cleveland Clinic.

Transcatheter aortic valve implantation for aortic stenosis

Current Evidence in TAVI patients using ACURATE and LOTUS valves

Are Heart Valve Referral Centers Feasible in Latin America?

TAVR: Review of the Robust Data from Randomized Trials

IPAC date: May of 13

Neal Kleiman, MD Houston Methodist DeBakey Heart and Vascular Institute

30-day Outcomes of The CENTERA Trial a New Self-Expanding Transcatheter Heart Valve. Didier Tchétché, MD On Behalf of the CENTERA Investigators

Transcription:

HA Convention 18-19 May 2015 The Impact of TAVI Nurse Coordinator on patient management of Transcatheter Aortic Valve Implantation (TAVI) program in QEH Division of Cardiology Department of Medicine Queen Elizabeth Hospital Kowloon Central Cluster Cecilia MC Chan 1, Michael KY Lee 1, CB Lam 1, C Leung 1, LK Chan 1, KC Chan 1, SF Chui 1, CY Wong 1, KT Chan 1 CS Chiang 1, MY Fan 1, KW Leung 1, HL Cheung 2, V Ng 2, E So 3, D Fok 3, MK Chan 4, W Chan 4, SF Yip 4, A Cheung 4 Department of Medicine 1 Department of Cardiothoracic Surgery 2 Department of Anaesthesiology 3 Department of Diagnostic Radiology & Imaging 4

Introduction Aortic Stenosis most common valvular heart disease in the elderly 4.6% in adults 75 years of age Healthy Aortic Valve Stenosed Aortic Valve

AVR Not performed in Some Patients with severe aortic stenosis if High surgical risk Short life expectancy Co-morbidities hindering GA, e.g. poor lung reserve Advanced age High frailty score Untreated Severe Aortic Stenosis Patients are at a High Risk for Death and a Poor Quality of Life repeated admission for symptom exacerbation

TAVI TAVI emerges as a viable alternative in inoperable or high risk elderly patients with symptomatic AS CoreValve Edwards Sapien Schoenhagen P et al. Eur Heart J 2009;30:2079-2086

CoreValve Transcatheter Procedure Balloon catheter threaded through sheath and into heart CoreValve in place, procedure completed CoreValve placed into position over the diseased aortic valve Experimental Device in the United States and Limited by Federal Law to Investigational Use.

Key to Success Patient Selection - Understand our patients - Meticulous patient assessment Multi-disciplinary TAVI Heart Team - Collaborative effort

Understanding Our Patients Comorbidities Quality of life Frailty Advanced age Disability Expectations Motivations

Consenting for Risks and Benefits Mortality Myocardial Infarction Stroke Bleeding Acute Kidney Injury Vascular Complications Conduction Disturbances Valvular Function

Multi-disciplinary TAVI Heart Team Cardiac Anesthesiolgists Radiologists Interventional Cardiologists Patients with Severe AS TAVI Nurse Coordinator Echo Cardiologist Cardiac surgeons

TAVI Nurse Coordinator s Duties Pre-operative Preparation Patient and family s education Cardiologists assessment Echocardiogram Independent assessment by cardiac surgeon Coronary angiogram + Peripheral angiogram CT aortogram TAVI Heart Team meeting

TAVI Nurse Coordinator s Duties Follow-up & Data collection Arrange FU 1 week, 1 month and then every 3-4 months Drug compliance checking: - Plavix for 3 months, Aspirin for life Echo at 1, 6, 12 months and then yearly 6 min walk test at 1, 6, 12 months SF-12 at 3 & 12 months NYHA functional class assessment Risk factors control

TAVI Nurse Coordinator s Duties Assist Patient s Assessment Diagnostic Work-Up Coordination Patient and Family Education Communicate among Heart Team Members Development of Program Forms Waitlist Management Communication With Referral Base Data Collection HA TAVI Audit Follow-Up Program Support for Research Clinical Coordination & Education Convenor Role General Admin & Data Mx

The Hong Kong Experience First TAVI performed at Queen Elizabeth Hospital on Dec 6 th, 2010 Medtronic CoreValve - 86 Center # of Cases Queen Elizabeth Hospital 49 Prince of Wales Hospital 26 Queen Mary Hospital 15 HK Adventist Hospital 10 Union Hospital 1 TOTAL 101 Edwards Sapien - 15

2-Year All-cause Mortality US CoreValve Pivotal Trial Vs QEH ACC 2015 QEH TAVI 14.3% 14.3% 19

30-Day Stroke Rate 20.0% 15.0% 10.0% 9.6% 5.0% 0.0% 4.5% 4.0% 4.0% 1.9% 2.5% 1.7% 1.8% 0.0% 18 Fr S&E 1 ANZ 2 French 3 Belgian 4 German 5 UK 6 Italian 8 Asia QEH 1. Medtronic. Data on file. COR 2006-02: 18 Fr Safety & Efficacy Study Re-Analysis, August 14, 2009. 2. Meredith. VARC-adjudicated Outcomes in Inoperable and High Risk AS Patients. TCT 2010, Washington, DC. 3. Eltchaninoff. French Registry, TAVI Facts, Figures and National Registries. EuroPCR 2010, Paris, France. 4. Bosmans. Belgian Registry, TAVI Facts, Figures and National Registries. EuroPCR 2010, Paris, France. 5. Zahn. German Registry, TAVI Facts, Figures and National Registries. EuroPCR 2010, Paris, France. 6. Ludman. UK Registry, TAVI Facts, Figures and National Registries. EuroPCR 2010, Paris, France. 7. Petronio. Italian Registry, TAVI Facts, Figures and National Registries. EuroPCR 2010, Paris, France.

Mean Gradient & Valve Area 60 2.5 QEH Registry Mean Gradient (mmhg) 50 40 30 20 10 0.7 49.7 2 1.97 1.96 1.87 1.9 MPG AVA 9.5 8.49 8.19 8.2 8.03 2 1.5 1 0.5 AVA (cm 2 ) 0 Baseline 30 days 6 months 1 year 2 years 3 years 0 The PARTNER Trial CoreValve ADVANCE Study

QEH Symptom Status (NYHA Class) 100% NYHA Classification Changes in NYHA Classification 80% 35% 59% 60% 86% 40% 55% Class I Improved 2 Classes 20% 35% Class II Class III Improved 1 Class Maintained 0% 10% 14% 6% Pre-TAVI Post-TAVI 30-day Post-TAVI 6-month Class IV * NYHA: New York Heart Association Functional Classification for Heart Failure Stages (Class I = Best, Class IV = Worst)

6-Minute Walk Test 280 257.6 260 Meters 240 220 215 200 Pre-TAVI Paired-sample t-test: p<0.05 Post-TAVI

Measurement for Quality of Life (SF-12) Physical Component 33.58 50.46 Pre-TAVI Post-TAVI Mental Component 52.63 58.36 30 35 40 45 50 55 60 Score Physical Component Paired-sample t-test: p<0.05 Mental Component Paired-sample t-test: p<0.05

Conclusions Queen Elizabeth Hospital is the first hospital to perform TAVI in Hong Kong and adopt TAVI coordinator TAVI Nurse coordinator enhances the process of care and clinical triage coordination Pivotal role of TAVI Nurse coordinator as the central hub for the smoother logistics of the TAVI program

TAVI 3-Year Celebration